Beyond Air (NASDAQ:XAIR – Get Free Report) is anticipated to announce its Q2 2026 results after the market closes on Monday, November 10th. Analysts expect the company to announce earnings of ($1.10) per share and revenue of $2.5360 million for the quarter. Beyond Air has set its FY 2026 guidance at EPS.Interested persons can check the company’s upcoming Q2 2026 earningsummary page for the latest details on the call scheduled for Monday, November 10, 2025 at 4:30 PM ET.
Beyond Air (NASDAQ:XAIR – Get Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported ($1.53) earnings per share for the quarter, missing the consensus estimate of ($1.50) by ($0.03). The company had revenue of $1.76 million during the quarter, compared to the consensus estimate of $1.75 million. Beyond Air had a negative net margin of 880.72% and a negative return on equity of 232.61%. On average, analysts expect Beyond Air to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Beyond Air Stock Up 3.0%
Shares of Beyond Air stock opened at $2.06 on Monday. The company has a current ratio of 3.24, a quick ratio of 2.71 and a debt-to-equity ratio of 0.92. Beyond Air has a 12-month low of $1.81 and a 12-month high of $13.52. The company has a market cap of $16.34 million, a P/E ratio of -0.17 and a beta of 0.30. The company’s fifty day simple moving average is $2.36 and its two-hundred day simple moving average is $3.14.
Analysts Set New Price Targets
Get Our Latest Analysis on Beyond Air
Hedge Funds Weigh In On Beyond Air
An institutional investor recently raised its position in Beyond Air stock. Osaic Holdings Inc. boosted its holdings in Beyond Air, Inc. (NASDAQ:XAIR – Free Report) by 26.4% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 162,560 shares of the company’s stock after buying an additional 34,000 shares during the quarter. Osaic Holdings Inc. owned 3.11% of Beyond Air worth $29,000 at the end of the most recent quarter. 31.50% of the stock is owned by institutional investors and hedge funds.
About Beyond Air
Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.
Further Reading
- Five stocks we like better than Beyond Air
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Put It on My Card: Why Luxury Brands and Payments Firms Pair Well
- Transportation Stocks Investing
- 3 Safe and Steady Stocks for Any Market
- What Are Some of the Best Large-Cap Stocks to Buy?
- Is Lemonade Stock Set for a Big Squeeze After Earnings?
Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.
